The months of October and November 2025 confirm the international vocation of Steriline, an Italian company specializing in robotic and non-robotic solutions for the aseptic filling and packaging of injectable products for the pharmaceutical sector. After successfully completing its participation at the CPHI in Frankfurt (October 28–30, 2025), Steriline is now preparing to meet partners and industry operators at CPHI & PMEC Delhi, scheduled from 25 to 27 November 2025.
CPHI 2025 in Frankfurt: a strategic presence at the heart of the European pharmaceutical industry
From 28 to 30 October, Steriline welcomed visitors, customers and partners at the stand Hall 9.0 – Booth 9.0F6 of Messe Frankfurt, presenting its range of complete sterile production lines. Participation represented a significant opportunity to strengthen relationships in key markets and discuss new production needs stemming from the growing demand for flexibility, safety, and operational continuity.At the centre of public interest, the integrated solutions with advanced robotics applied to processes such as filling, capping and sealing: technologies designed to reduce contamination risks, improve operational ergonomics and optimise efficiency even in adaptive or small batch production contexts.
Next stop: CPHI & PMEC Delhi 2025
From November 25st to 27th, Steriline will be present at CPHI & PMEC in New Delhi, at stand 10.D23For the occasion, the company will present a 3D demonstration model reproducing a robotic line for sterile filling: a solution designed to ensure maximum precision and repeatability without the risk of contamination.The model will allow visitors to directly explore key elements of the production architecture, including:
- seamless integration between robotics and containment systems (insulators);
- adaptability to different types of containers;
- reduction of critical operating variables;
- Layout optimization for GMP environments.
It might interest you
Read more onThematic Contents
"The Indian market has been at the heart of our development strategy for years," he has declared Federico Fumagalli, Chief Sales Officer of Steriline. "Participation in CPHI & PMEC Delhi 2025 represents a key opportunity to engage with one of the most dynamic hubs of the global pharmaceutical industry and present solutions capable of responding to a constantly evolving sector."
An ever-growing international presence
The double presence between Europe and Asia once again testifies to the Steriline's global vision: to be the technological partner of choice for pharmaceutical companies of all sizes, placing the four cornerstones of aseptic processing for the pharmaceutical sector at the heart of its growth: quality, safety, sustainability and continuous innovation.With operational and technical offices already present in Europe, Asia and North America, Steriline consolidates a local and global support network capable of accompanying customers through all phases of the production cycle, from engineering to validation, up to post-installation assistance.
Contact Information
With a network of over 400 professionals and a consolidated presence in over 50 countries, Steriline exports more than 90% of its machinery, for a fleet that well exceeds 2.000 installations worldwide. Constant attention to technological innovation, the development of internal expertise, and active participation in major international events in the sector confirm the company's role as a global reference point in primary packagingfor the pharmaceutical sector.
Contacts Steriline Srl
Via Tentorio, 30/31 - 22100 Como, Italy
Tel. +39 031 592064
Corporate website: www.steriline.it
LinkedIn page: https://it.linkedin.com/company/steriline-srl
Leave a comment